Kryptonite for cancer cells

(Phys.org) —Every available cancer drug is susceptible to resistance, according to Mansoor Amiji, Distinguished Professor and chair of the Department of Pharmaceutical Sciences. Tumors grow more quickly than blood vessels, ...

Understanding how cells respond to nanoparticles

Gold nanoparticles are showing real promise as vehicles for efficiently delivering therapeutic nucleic acids, such as disease-fighting genes and small interfering RNA (siRNA) molecules, to tumors. Now, a team of investigators ...

Image-guided breast cancer therapy enabled by nanodrug

By combining an iron oxide nanoparticle, a tumor-targeting peptide, and a therapeutic nucleic acid into one construct, a team of investigators from the Massachusetts General Hospital and Harvard Medical School have created ...

Shining a light on gene regulation

Cancer treatments—from radiation to surgery to chemotherapy—are designed to remove or kill cancerous cells, but healthy cells often become collateral damage in the process. What if you could use lasers to pinpoint the ...

New nanomedicine slips through the cracks

In a recent study in mice, researchers found a way to deliver specific drugs to parts of the body that are exceptionally difficult to access. Their Y-shaped block catiomer (YBC) binds with certain therapeutic materials forming ...

page 2 from 3